Pharmapace, Inc. (“Pharmapace”) is a consulting and contract Clinical Research Organization (“CRO”) founded by a group of veteran leaders in the biotech/pharmaceutical industry who are recognized experts in their respective fields. The four co-founders had worked together to successfully conduct multiple regulatory submissions that had led to product approvals. The experience Pharmapace delivers spans across all phases of drug development as well as post-marketing product support.
Pharmapace’s core mission is to deliver exceptional value to biotech/pharmaceutical companies by providing high-quality consulting and outsourcing services to support our customer’s clinical trials, regulatory submissions, medical affairs, safety surveillance, and outcomes research programs to help patients afflicted with a wide range of disease conditions.
Key value propositions that Pharmapace has developed, cover four dimensions: customer-focus with tremendous flexibility, quality (both operational and scientific), efficiency, and compliance. Pharmapace intends to be flexible in meeting customer needs. Pharmapace will effectively match customized delivery solutions with client’s project goals and financial capabilities.
The Pharmapace vision is to become one of the best consulting & outsourcing companies with an emphasis on delivering excellent value and quality to customers by attracting, training, and retaining quality employees. Pharmapace strives for continual improvement to ensure that we meet customers’ scientific and operational quality standards and cost requirements, while offering scalability and adaptability to all our customers and their development programs.
Since our founding in 2013, Pharmapace has successfully assisted numerous biopharmaceutical companies in their drug development programs. Many of the drugs that our team has worked on have received approval by the US Food and Drug Administration. We take great pride in what we do to help our valued customers to advance human health.
In early 2019, Pharmapace was acquired by WuXi AppTec, a company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Pharmapace will continue to operate as a California corporation as a subsidiary of WuXi AppTec and will remain committed to delivering exceptional services and value to our customers. Pharmapace will be an integral part of WuXi Clinical which has offices in Austin, Texas, Taiwan, and China. This combination allows us to leverage on WuXi Clinical’s vast resources and offer our customers a truly global solution to all aspects of clinical/drug development and regulatory submission. It also provides both high level of flexibility and more pricing advantages.
Clinical Development Strategy
Clinical Study Design
Clinical Study Reports
Statistical Analysis Plan (SAP)
CDISC (SEND, CDASH, SDTM, & ADaM) Implementation
Database Construction and Integration
Data Analysis and ReportingData Mining and Analysis for Publication